CHAP Annual Meetings

The following sponsors generously support the annual meeting of the group.

Meeting DateSponsorsLocation
April 26, 2023 and CHAP Chats seriesGold: Gilead, Merck
Silver: ViiV, Pfizer
Other: Abbvie
Quebec City, QC
May 25th, 2022 and CHAP Chats seriesAbbvie, Gilead, Merck, ViiVVirtual Meeting
May 4th, 2021 and CHAP Chats seriesAbbvie, Gilead, Merck, ViiVVirtual Meeting
April 29, 2020n/aVirtual Meeting
May 8, 2019Gold: Gilead
Silver: Viiv, Abbvie
Bronze: Merck
Other: Theratechnologies
Saskatoon, SK
April 25, 2018Gold: Gilead, Merck
Silver: Viiv
Bronze: Abbvie
Other: Theratechnologies
Vancouver, BC
April 5, 2017Gilead, Merck, ViiV, TheratechnologiesMontreal, QC
May 11, 2016Gilead, Merck, ViiV, AbbVieWinnipeg, MB
April 29, 2015Gilead, Merck, Janssen, ViiV, AbbVieToronto, ON
April 30, 2014AbbVie, Gilead, Janssen,
BMS, Merck, ViiV
St. Johns, NL
April 10, 2013Gilead, Merck, BMS
Janssen, ViiV, AbbVie
Vancouver, BC
April 22-23, 2012Gold: Gilead, BMS.
Bronze: Abbot, Boehringer, Ingelheim,
Janssen, Merck, ViiV
Montreal, QC
April 13, 2011Abbot, BMS, Gilead,
Janssen, Merck, ViiV
Toronto, ON
May 12, 2010Gilead, Merck, Abbott, BMSSaskatoon, SK
April 22, 2009GileadVancouver, BC
April 23, 2008GileadMontreal, QC
April 25, 2007GileadToronto, ON
May 24, 2006BMS, GileadQuebec City, QC
May 11-12, 2005BMSVancouver, BC
May 12, 2004BMSMontreal, QC
April 10, 2003AbbottHalifax, NS
April 24, 2002AbbottWinnipeg, MN
May 30-31, 2001Merck FrosstToronto, ON
April 27, 2000Merck FrosstMontreal, QC
January 30, 1999Merck FrosstChicago, IL
January 30, 1998Merck FrosstChicago, IL

Additional Support

The CHAP website is supported by the Toronto General Hospital Immunodeficiency Clinic.

The logistical costs (e.g., room bookings, travel grants, equipment rental) of the annual network meeting are supported by the sponsor(s) listed above through an unrestricted educational grant.

Members do not receive any honoraria for participating in CHAP activities.

CHAP Logo with name

Goals:

To promote cross-country sharing of experiences and information to improve patient care.

To develop practical, clinical guidelines on the role of the pharmacist in caring for patients with HIV and/or viral hepatitis.

To collaborate on research protocols which demonstrate positive drug-related outcomes.

To share continuing education resources, in order to make information on HIV and/or viral hepatitis drug therapy more accessible to community, hospital and ambulatory pharmacists, as well as patients.

To foster the development of HIV and/or viral hepatitis pharmacist mentors.

To promote the pharmacists role in HIV and/or viral hepatitis therapeutics on a national level.